The U.S. Food and Drug Administration has approved the expanded use of ​Travere Therapeutics' drug to treat a rare kidney ...

Add Yahoo as a preferred source to see more of our stories on Google. The drug finerenone, made by pharma giant Bayer and marketed under the brand name Kerendia, was found to be effective in treating ...

Travere Therapeutics received approval from the Food and Drug Administration for a treatment for a rare kidney disorder. The biopharmaceutical company said Monday the approval is for its Filspari drug ...

A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for people with hard-to-treat hypertension. The medication, baxdrostat, reduces ...

Serious damage to short-term kidney function—known as acute kidney injury, or AKI—can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ...

Rare kidney trials miss enrollment timelines for the same reason most clinical projects fail: eligible patients reach sites too slowly and in insufficient numbers.

For the silent multitaskers in our body, the kidneys, which filter waste, balance fluids, regulate blood pressure, and support red blood cell production, their health should be paramount. Because when ...

Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial. The drug, povetacicept, is a central piece of the company's plan to expand into kidney disease. Vertex ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of recurrent kidney stones and gout flare-ups, finds a study from Canada ...

The African turquoise killifish ages so quickly that its entire life story can unfold between one human birthday and the next. That compressed timeline is helping scientists watch kidney aging in fast ...